Trapping cancer-driving DNA in micronuclei reveals a potential tumor vulnerability
Published in Biology, Diseases!, Journals.
Published October 18, 2026.
A study published in Nature Genetics on October 12 examines a potential weakness in cancers driven by extrachromosomal DNA, or ecDNA. These DNA rings can carry multiple copies of cancer-promoting genes.
Using live-cell imaging and sequencing of individual micronuclei, researchers investigated what happens when ecDNA becomes trapped outside the main cell nucleus. Under replication stress, the rings clustered and were more frequently misdirected into micronuclei during cell division.
Once sequestered, their transcriptional activity declined. Cells inheriting ecDNA-containing micronuclei showed reduced proliferation and a greater likelihood of dying, suggesting that the location of these DNA rings can influence tumor-cell fitness.
In neuroblastoma patient samples, the presence of micronuclear ecDNA was also associated with more favorable survival. That observation supports further investigation but does not establish that deliberately inducing micronuclei improves patient outcomes.
The findings suggest a possible therapeutic strategy: redirect cancer-driving DNA away from the nucleus. Developing a safe, effective intervention remains a separate challenge. This study provides mechanistic and observational evidence, rather than results from a clinical trial testing such a treatment.
Sources: Nature Genetics, October 12, 2026; Max Delbrück Center, October 12, 2026.